We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.512
Bid: 1.502
Ask: 1.83
Change: 0.00 (0.00%)
Spread: 0.328 (21.838%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Separate Results

9 Nov 2017 07:00

RNS Number : 9534V
Commercial Intnl Bank (Egypt) SAE
09 November 2017
 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

September 30th , 2017

 

 

 

 

FINANCIAL POSITION

As of September 30th , 2017

Amounts in EGP Thousands

Note

September 30, 2017

 

December 31, 2016

 

Assets

Cash and balances with central bank

15

23,174,630

10,522,040

Due from banks

16

38,891,261

58,011,034

Treasury bills and other governmental notes

17

54,950,084

39,177,184

Trading financial assets

18

4,599,462

2,445,134

Loans and advances to banks, net

19

1,207

159,651

Loans and advances to customers, net

20

87,996,206

85,991,914

Derivative financial instruments

21

68,570

269,269

Financial investments

- Available for sale

22

17,781,240

5,447,291

- Held to maturity

22

47,494,845

53,924,936

Investments in associates

23

9,750

10,500

Non current assets held for sale

42

-

428,011

Other assets

24

5,953,798

5,446,025

Intangible assets

41

401,475

499,131

Deferred tax assets (Liabilities)

32

171,593

181,308

Property, plant and equipment

25

1,342,886

1,338,629

Total assets

282,837,007

 

263,852,057

Liabilities and equity

Liabilities

Due to banks

26

664,401

3,008,996

Due to customers

27

247,733,684

231,965,312

Derivative financial instruments

21

154,420

331,091

Current tax liabilities

1,945,105

2,017,034

Other liabilities

29

4,119,256

3,579,330

Long term loans

28

141,406

160,243

Other provisions

30

1,518,570

1,514,057

Total liabilities

256,276,842

242,576,063

Equity

Issued and paid up capital

31

11,618,011

11,538,660

Reserves

34

8,824,048

3,443,319

Reserve for employee stock ownership plan (ESOP)

428,807

343,460

Total equity

20,870,866

15,325,439

Net profit for the period/year

5,689,299

5,950,555

Total equity and net profit for the period/ year

26,560,165

21,275,994

Total liabilities and equity

282,837,007

263,852,057

INCOME STATEMENT

As of September 30, 2017

Amounts in EGP Thousands

Note

September 30, 2017

 

September 30, 2016

 

Interest and similar income

21,008,359

13,486,623

Interest and similar expense

(11,698,658)

(6,420,760)

Net interest income

6

9,309,701

7,065,863

Fee and commission income

2,019,148

1,385,726

Fee and commission expense

(435,430)

(279,399)

Net fee and commission income

7

1,583,718

1,106,327

Dividend income

8

27,844

32,019

Net trading income

9

908,024

696,412

Profits on financial investments

22

337,726

44,236

Administrative expenses

10

(2,262,632)

(1,793,713)

Other operating (expenses) income

11

(730,741)

(557,683)

Goodwill impairment

41

-

(32,561)

Intangible assets amortization

41

(97,656)

(97,656)

Impairment charge for credit losses

12

(1,431,865)

(577,684)

Profit before income tax

7,644,119

5,885,560

Income tax expense

13

(1,945,105)

(1,452,955)

Deferred tax assets (Liabilities)

32 & 13

(9,715)

(91)

Net profit for the Period

5,689,299

4,432,514

Earnings per share

14

Basic

4.34

3.38

Diluted

4.27

3.33

CASH FLOW STATEMENT

As of September 30, 2017

 

 

 

Amounts in EGP Thousands

 

September 30, 2017

September 30, 2016

Cash flow from operating activities

Profit before income tax

7,644,119

 

5,885,560

 

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

263,524

205,146

Impairment charge for credit losses

1,431,865

577,684

Other provisions charges

119,983

165,575

Trading financial investments revaluation differences

(269,480)

50,748

Available for sale and held to maturity investments exchange revaluation differences

115,734

(263,567)

Goodwill impairment

-

32,561

Intangible assets amortization

97,656

97,656

Financial investments impairment charge

(96,182)

46,492

Utilization of other provisions

(19,951)

(2,822)

Other provisions no longer used

(97,884)

(47,405)

Exchange differences of other provisions

2,365

60,254

Profits from selling property, plant and equipment

(607)

(575)

Profits from selling financial investments

101,546

(10,935)

Profits (losses) from selling associates

-

(84,948)

Shares based payments

230,357

145,981

Impairment (Released) charges of non-current assets held for sale

(330,934)

-

 

Operating profits before changes in operating assets and liabilities

 

9,192,111

6,857,405

Net decrease (increase) in assets and liabilities

Due from banks

(7,919,523)

(2,042,595)

Treasury bills and other governmental notes

(16,875,364)

538,374

Trading financial assets

(1,884,848)

2,135,885

Derivative financial instruments

24,028

(65,136)

Loans and advances to banks and customers

(3,277,713)

(4,601,222)

Other assets

(307,248)

541,151

Non-Current Assets Held for Sale

428,011

-

Due to banks

(2,344,595)

(1,123,107)

Due to customers

15,768,372

22,800,375

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

539,926

265,769

Net cash provided from operating activities

(8,673,877)

23,357,205

Cash flow from investing activities

Proceeds from selling subsidiary and associates

750

161,503

Payment for purchases of property, plant, equipment and branches constructions

(467,699)

(439,372)

Proceeds from redemption of held to maturity financial investments

11,026,150

4,094

Payment for purchases of held to maturity financial investments

(4,596,059)

(2,367,123)

Payment for purchases of available for sale financial investments

(13,263,959)

(3,024,361)

Proceeds from selling available for sale financial investments

1,146,696

4,427,351

Proceeds from selling non-current assets held for sale

628,521

-

Net cash used in investing activities

(5,525,600)

(1,237,908)

Cash flow from financing activities

Increase (decrease) in long term loans

(18,837)

16,300

Dividend paid

(1,350,207)

(1,463,450)

Capital Increase

79,351

68,057

Net cash used in financing activities

(1,289,693)

(1,381,869)

 

Net increase (decrease) in cash and cash equivalent during the period

(15,489,170)

20,740,204

Beginning balance of cash and cash equivalent

61,518,700

22,583,060

Cash and cash equivalent at the end of the period

46,029,530

43,323,264

Cash and cash equivalent comprise:

Cash and balances with central bank

23,174,630

12,434,973

Due from banks

38,891,261

41,177,611

Treasury bills and other governmental notes

54,950,084

21,613,272

Obligatory reserve balance with CBE

(12,666,252)

(9,846,334)

Due from banks with maturities more than three months

(3,257,401)

(464,462)

Treasury bills with maturity more than three months

(55,062,792)

(21,591,796)

Total cash and cash equivalent

46,029,530

43,323,264

 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

 

Separate statement of changes in shareholders' equity for the period ended September 30, 2016

Sep. 30, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

4,640,718

248,148

16,511,613

Capital increase

68,057

-

-

-

-

-

-

-

68,057

Transferred to reserves

-

232,008

3,035,878

564

-

-

(3,176,762)

(91,688)

-

Dividend paid

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

Net profit for the period

-

-

-

-

-

-

4,432,514

-

4,432,514

Net unrealised gain/(loss) on AFS

-

-

-

-

(546,224)

-

-

-

(546,224)

Transferred (from) to bank risk reserve

-

-

-

-

-

506

(506)

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

145,981

145,981

Balance at the end of the period

11,538,660

1,035,363

4,554,403

30,778

(2,748,687)

3,019

4,432,514

302,441

19,148,491

 

 

 

Separate statement of changes in shareholders' equity for the period ended September 30, 2017

 

Sep. 30, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

5,950,555

343,460

21,275,994

 

Capital increase

79,351

-

-

-

-

-

-

-

79,351

 

Transferred to reserves

-

297,444

4,445,617

1,682

-

-

(4,599,733)

(145,010)

-

 

Dividend paid

-

-

-

-

-

-

(1,350,207)

-

(1,350,207)

 

Net profit for the period

-

-

-

-

-

-

5,689,299

-

5,689,299

 

Net unrealised gain/(loss) on AFS

-

-

-

-

635,371

-

-

-

635,371

 

Transferred (from) to bank risk reserve

-

-

-

-

-

615

(615)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

230,357

230,357

 

Balance at the end of the period

11,618,011

1,332,807

9,000,020

32,460

(1,544,873)

3,634

5,689,299

428,807

26,560,165

 

 

 

 

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/9534V_-2017-11-8.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTKMMGMDRNGNZM
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.